AMRUTANJAN
Amrutanjan Health Care Limited (AMRUTANJAN) Stock Analysis
Amrutanjan Health Care Limited is an Indian FMCG and OTC healthcare company known for pain balms and wellness products. It markets brands in pain relief, beverages, and personal care through retail networks. The company has a long consumer brand heritage in South India. It is a listed consumer healthcare stock.
Healthcare › Drug Manufacturers - Specialty & Generic
₹519.90
+4.15% 1W | -26.40% 52W
Market Cap
1.5k CR
P/E Ratio
27.8
52W High
₹744
52W Low
₹476.5
Div. Yield
0.98%
Beta
0.4
50 DMA
₹502.7
200 DMA
₹537.7
Profit Margin
10.6%
Inst. Own.
10.5%
🔥 APPROACHING RESISTANCE
🔥 APPROACHING RESISTANCE
Fundamentals
Profit & Loss
No profit & loss data available.
| Metric | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 67 | 69 | 71 | 87 | 86 | 101 | 136 | 131 | 134 | 158 | 177 |
| Sales growth | +3% | +3% | +22% | -1% | +17% | +35% | -4% | +3% | +17% | +12% | |
| Expenses | 53 | 53 | 60 | 182 | 76 | 88 | 118 | 113 | 112 | 134 | 145 |
| Operating Profit | 13 | 16 | 11 | -95 | 10 | 13 | 18 | 17 | 22 | 24 | 31 |
| OPM % | 20% | 23% | 16% | -109% | 12% | 13% | 13% | 13% | 16% | 15% | 18% |
| Other Income | 1 | -2 | 0 | 220 | 10 | 5 | 4 | 4 | 3 | 4 | 5 |
| Interest | 1 | 1 | 1 | 0 | 0 | 1 | 3 | 2 | 2 | 1 | 0 |
| Depreciation | 3 | 2 | 2 | 2 | 1 | 2 | 3 | 4 | 4 | 3 | 3 |
| Profit before tax | 11 | 11 | 9 | 123 | 19 | 15 | 16 | 15 | 19 | 24 | 33 |
| Tax % | 45% | 46% | 42% | 25% | 38% | 34% | 39% | 35% | 36% | 38% | 37% |
| Net Profit | 6 | 6 | 5 | 92 | 11 | 10 | 10 | 10 | 12 | 15 | 21 |
| EPS in Rs | 29.80 | 3.32 | 3.47 | 4.26 | 5.10 | 7.05 | |||||
| Dividend Payout % | 22% | 32% | 45% | 19% | 40% | 45% | 45% | 43% | 38% | 34% | 27% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 11.0% | 12.0% | 10.0% |
| Profit CAGR | 27.0% | 15.0% | 13.0% |
Shareholding Pattern
Promoters46.52%
FIIs2.38%
DIIs12.90%
Public38.16%
Promoters46.52%
FIIs2.27%
DIIs13.00%
Public38.18%
Promoters46.52%
FIIs2.17%
DIIs12.66%
Public38.61%
Promoters46.52%
FIIs2.44%
DIIs12.29%
Public38.72%
Promoters46.52%
FIIs3.47%
DIIs6.90%
Public43.08%
Promoters50.03%
FIIs0.68%
DIIs7.18%
Public41.93%
Promoters50.59%
FIIs1.38%
DIIs7.29%
Public40.66%
Promoters46.52%
FIIs2.30%
DIIs11.41%
Public39.75%
Promoters46.52%
FIIs2.17%
DIIs12.66%
Public38.61%
Promoters46.52%
FIIs3.47%
DIIs6.90%
Public43.08%
AMRUTANJAN
Holdings Analysis
Key strengths & risk signals
56
Overall
59
Fundamental
54
Technical
Risks (3)
TOO MUCH PUBLIC HOLDING! 41.87% public ownership - higher volatility risk.
POOR YEAR! Stock declined 26.4% in the last year.
WEAK! Trading at 16.2% of 52W range - near yearly lows.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
LOW VOLATILITY! Beta of 0.40 - stable stock, less market risk.
BULLISH SENTIMENT! In last 30 days: 20 up days, 10 down days. Avg volume on up days: 40,068 vs down days: 34,810. Ratio: 1.15x
MIXED POSITION! Current price (519.9) above 50-day but below 200-day.
Fundamental & Technical Analysis
56Overall
59Fundamental
54Technical
Fundamental Breakdown
Growth Quality
19/30
Revenue CAGR: 9.9% (MODERATE, 8/15). Profit CAGR: 13.3% (GOOD, 11/15).
Profit Margin
5/10
DECENT EFFICIENCY! 10.6% profit margin - acceptable profitability.
PEG Valuation
7/10
OVERVALUED! PEG of 2.09 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.98% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 41.87% public ownership - higher volatility risk.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (502.7) is below 200-day average (537.7) - negative signal.
Price Position
6/10
MIXED POSITION! Current price (519.9) above 50-day but below 200-day.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
1/10
POOR YEAR! Stock declined 26.4% in the last year.
Volume Sentiment
20/30
BULLISH SENTIMENT! In last 30 days: 20 up days, 10 down days. Avg volume on up days: 40,068 vs down days: 34,810. Ratio: 1.15x
RSI
3/5
NEUTRAL! RSI at 56.2 - balanced momentum.
52W Range
1/5
WEAK! Trading at 16.2% of 52W range - near yearly lows.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 4.2% (1 week), 2.1% (1 month), -2.6% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.40 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMRUTANJAN | ₹519.90 | 27.8 | 10.6% | 9.9% | 13.3% | -26.4% | 56 | APPROACHING RESISTANCE | -47.0% | -72.8% | +9.6% | -31.2% |
| JAGSNPHARM | ₹217.40 | 32.6 | 14.3% | 6.7% | 17.3% | +2.1% | 69 | BREAKDOWN | -2.4% | -6.8% | +29.4% | +17.3% |
| AHCL | ₹26.90 | 50.8 | 12.8% | 15.1% | 69.8% | +95.3% | 75 | BREAKDOWN | +44.1% | +100.0% | +102.3% | +20.5% |
| FERMENTA | ₹430.40 | 19.7 | 11.7% | 14.5% | – | +0.2% | 62 | BREAKDOWN | -55.5% | -49.5% | -10.6% | +0.2% |
| SYNCOMF | ₹20.10 | 21.4 | 17.2% | 29.4% | 56.2% | +30.6% | 75 | APPROACHING SUPPORT | +57.0% | -1.6% | +7.4% | -7.3% |
| BAFNAPH | ₹472.80 | 143.7 | 5.5% | 9.3% | -0.7% | +152.9% | 62 | BREAKOUT | -97.1% | -96.3% | -23.1% | -37.0% |
| VENUSREM | ₹1,719.50 | 22.4 | 13.4% | 11.6% | 57.0% | +264.9% | 74 | BREAKDOWN | +126.2% | +85.5% | +31.2% | +43.9% |
| BETA | ₹1,881.60 | 28.7 | 11.1% | 27.0% | 29.0% | +7.6% | 74 | BREAKDOWN | +55.7% | +20.3% | +32.5% | +9.2% |
Data from TradeAlone · Updated daily
